Opko Health (OPK) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.53, -4.97% vs the prior close of $1.61.
- Volume 11.97M shares, 3.4x its 50-day average (heavy).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
OPK slides 5.0% to $1.53 on 3.4x normal volume. Closed at $1.53, -4.97% vs the prior close of $1.61. Day range $1.50–$1.77, opened at $1.73.
OPK daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — OPK slides 5.0% to $1.53 on 3.4x normal volume
- Closed at $1.53, -4.97% vs the prior close of $1.61. Day range $1.50–$1.77, opened at $1.73.
- Volume was 11.97M shares, 3.4x its 50-day average of 3.56M — unusually heavy trading.
- Price is +0.9% vs its 50-day average ($1.52) and +15.2% vs its 200-day average ($1.33).
- 52-week range $0.98–$1.77; today's close sits at 70% of that range, 13.6% below the 52-week high.
Oct 15, 2026 — OPK jumps 17.5% to $1.61 on 22.1x normal volume
- Closed at $1.61, +17.52% vs the prior close of $1.37. Day range $1.48–$1.70, opened at $1.65.
- Volume was 55.35M shares, 22.1x its 50-day average of 2.51M — unusually heavy trading.
- Price is +6.5% vs its 50-day average ($1.51) and +21.3% vs its 200-day average ($1.33).
- 52-week range $0.98–$1.75; today's close sits at 82% of that range, 8.0% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — OPK jumps 3.8% to $1.37
- Closed at $1.37, +3.79% vs the prior close of $1.32. Day range $1.30–$1.37, opened at $1.31.
- Volume was 1.64M shares, 0.6x its 50-day average of 2.55M.
- Price is -9.1% vs its 50-day average ($1.51) and +3.4% vs its 200-day average ($1.33).
- 52-week range $0.98–$1.75; today's close sits at 51% of that range, 21.7% below the 52-week high.
Oct 13, 2026 — OPK slides 4.3% to $1.32, a 1-month low
- Closed at $1.32, -4.35% vs the prior close of $1.38. Day range $1.32–$1.39, opened at $1.38.
- Volume was 1.56M shares, 0.6x its 50-day average of 2.61M — lighter than usual.
- Price is -12.3% vs its 50-day average ($1.51) and -0.4% vs its 200-day average ($1.33).
- 52-week range $0.98–$1.75; today's close sits at 44% of that range, 24.6% below the 52-week high.
Oct 12, 2026 — OPK ends flat (+0.0%) to $1.38
- Closed at $1.38, +0.00% vs the prior close of $1.38. Day range $1.36–$1.39, opened at $1.38.
- Volume was 1.01M shares, 0.4x its 50-day average of 2.65M — lighter than usual.
- Price is -8.3% vs its 50-day average ($1.51) and +4.2% vs its 200-day average ($1.32).
- 52-week range $0.98–$1.75; today's close sits at 52% of that range, 21.1% below the 52-week high.
Oct 9, 2026 — OPK rises 0.7% to $1.38
- Closed at $1.38, +0.73% vs the prior close of $1.37. Day range $1.37–$1.42, opened at $1.38.
- Volume was 1.09M shares, 0.4x its 50-day average of 2.69M — lighter than usual.
- Price is -8.3% vs its 50-day average ($1.50) and +4.2% vs its 200-day average ($1.32).
- 52-week range $0.98–$1.75; today's close sits at 52% of that range, 21.1% below the 52-week high.
Oct 8, 2026 — OPK dips 1.4% to $1.37, a 1-month low, 3 down days in a row
- Closed at $1.37, -1.44% vs the prior close of $1.39. Day range $1.34–$1.40, opened at $1.37.
- Volume was 2.47M shares, 0.9x its 50-day average of 2.82M.
- Price is -8.9% vs its 50-day average ($1.50) and +3.4% vs its 200-day average ($1.32).
- 52-week range $0.98–$1.75; today's close sits at 51% of that range, 21.7% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — OPK slides 4.8% to $1.39, a 1-month low
- Closed at $1.39, -4.79% vs the prior close of $1.46. Day range $1.38–$1.43, opened at $1.42.
- Volume was 2.22M shares, 0.6x its 50-day average of 3.47M.
- Price is -7.6% vs its 50-day average ($1.50) and +5.0% vs its 200-day average ($1.32).
- 52-week range $0.98–$1.75; today's close sits at 53% of that range, 20.6% below the 52-week high.
Oct 6, 2026 — OPK slides 7.0% to $1.46, a 1-month low
- Closed at $1.46, -7.01% vs the prior close of $1.57. Day range $1.46–$1.59, opened at $1.59.
- Volume was 2.45M shares, 0.7x its 50-day average of 3.51M.
- Price is -3.2% vs its 50-day average ($1.51) and +10.3% vs its 200-day average ($1.32).
- 52-week range $0.98–$1.75; today's close sits at 62% of that range, 16.6% below the 52-week high.
Oct 5, 2026 — OPK rises 0.6% to $1.57
- Closed at $1.57, +0.64% vs the prior close of $1.56. Day range $1.54–$1.59, opened at $1.56.
- Volume was 1.65M shares, 0.5x its 50-day average of 3.53M — lighter than usual.
- Price is +4.4% vs its 50-day average ($1.50) and +18.7% vs its 200-day average ($1.32).
- 52-week range $0.98–$1.75; today's close sits at 77% of that range, 10.3% below the 52-week high.
Oct 2, 2026 — OPK dips 0.6% to $1.56, 8 down days in a row
- Closed at $1.56, -0.64% vs the prior close of $1.57. Day range $1.55–$1.58, opened at $1.58.
- Volume was 1.40M shares, 0.4x its 50-day average of 3.56M — lighter than usual.
- Price is +4.2% vs its 50-day average ($1.50) and +18.0% vs its 200-day average ($1.32).
- 52-week range $0.98–$1.75; today's close sits at 75% of that range, 10.9% below the 52-week high.
- That makes 8 straight losses.
- SEC filings that day: 8-K.
OPK latest news & SEC filings
Every SEC filing by or about OPK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 28, 2026 · Form 10-Q/A — Quarterly report (amended)
Amended quarterly report
Quarter ended Jun 30, 2026:
- Revenue: $163.58M (prior year $156.81M) (+4.3% vs Jun 30, 2025)
- Net income: -$8.42M (prior year -$148.44M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.01 (prior year -$0.19) (loss narrowed vs Jun 30, 2025)
Aug 28, 2026 · Form 10-Q/A — Quarterly report (amended)
Amended quarterly report
Quarter ended Mar 31, 2026:
- Revenue: $124.20M (prior year $149.95M) (-17.2% vs Mar 31, 2025)
- Net income: -$54.85M (prior year -$67.61M) (loss narrowed vs Mar 31, 2025)
- Diluted EPS: -$0.07 (prior year -$0.10) (loss narrowed vs Mar 31, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Aug 7, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 27, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $163.58M (prior year $156.81M) (+4.3% vs Jun 30, 2025)
- Net income: -$8.42M (prior year -$148.44M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.01 (prior year -$0.19) (loss narrowed vs Jun 30, 2025)
Jul 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 1, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade OPK
- Last results release: Jul 27, 2026 (8-K Item 2.02). Previous ones: Apr 28, 2026, Feb 26, 2026, Oct 29, 2025. Based on that rhythm, the next report is likely around Oct 26, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.95% (largest 17.5%).
- Liquidity: about 5.12M shares (≈$7.83M) trade per day on average.
- 52-week position: $1.53 vs a range of $0.98–$1.77 (70% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: John A Paganelli bought 10,000 shares on Mar 20, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 2, 2026; 8-K Aug 14, 2026.
- Share count: 746.33M shares outstanding (Jul 17, 2026), -6.0% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
OPK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.73 | 1.77 | 1.50 | 1.53 | 11.97M |
| Oct 15, 2026 | 1.65 | 1.70 | 1.48 | 1.61 | 55.45M |
| Oct 14, 2026 | 1.31 | 1.37 | 1.30 | 1.37 | 1.64M |
| Oct 13, 2026 | 1.38 | 1.39 | 1.32 | 1.32 | 1.56M |
| Oct 12, 2026 | 1.38 | 1.39 | 1.36 | 1.38 | 1.01M |
| Oct 9, 2026 | 1.38 | 1.42 | 1.37 | 1.38 | 1.09M |
| Oct 8, 2026 | 1.37 | 1.40 | 1.34 | 1.37 | 2.47M |
| Oct 7, 2026 | 1.42 | 1.43 | 1.38 | 1.39 | 2.22M |
| Oct 6, 2026 | 1.59 | 1.59 | 1.46 | 1.46 | 2.45M |
| Oct 5, 2026 | 1.56 | 1.59 | 1.54 | 1.57 | 1.65M |
| Oct 2, 2026 | 1.58 | 1.58 | 1.55 | 1.56 | 1.40M |
| Oct 1, 2026 | 1.61 | 1.61 | 1.55 | 1.57 | 2.49M |
| Sep 30, 2026 | 1.63 | 1.64 | 1.60 | 1.61 | 2.39M |
| Sep 29, 2026 | 1.62 | 1.64 | 1.61 | 1.62 | 1.73M |
| Sep 28, 2026 | 1.64 | 1.65 | 1.61 | 1.63 | 1.61M |
| Sep 25, 2026 | 1.65 | 1.66 | 1.62 | 1.64 | 1.53M |
| Sep 24, 2026 | 1.69 | 1.70 | 1.62 | 1.64 | 2.70M |
| Sep 23, 2026 | 1.71 | 1.74 | 1.68 | 1.70 | 1.78M |
| Sep 22, 2026 | 1.70 | 1.75 | 1.69 | 1.73 | 3.48M |
| Sep 21, 2026 | 1.67 | 1.69 | 1.64 | 1.69 | 1.78M |
About Opko Health
Opko Health (OPK) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MIAMI, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 944809.
OPK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Phillip Md Et Al Frost | CEO & Chairman | Nov 21, 2025 |
| Prem A Lachman | Director | Jun 22, 2026 |
| Roger Md Medel | Director | Jun 22, 2026 |
| John A Paganelli | Director | Jun 22, 2026 |
| Richard C Jr Pfenniger | Director | Jun 22, 2026 |
| Steven D Rubin | Executive VP-Administration | Jul 28, 2026 |
| Subbarao V Uppaluri | Director | Jun 22, 2026 |
| Alice Lin-Tsing Yu | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Phillip Md Et Al Frost | CEO & Chairman | Nov 21, 2025 |
| Adam Logal | Sr. Vice President, CFO | Jul 28, 2026 |
| Steven D Rubin | Executive VP-Administration | Jul 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 20, 2026 | John A Paganelli | Buy | 10,000 | $1.14 |
| Mar 20, 2026 | John A Paganelli | Buy | 10,000 | $1.14 |
| Mar 20, 2026 | John A Paganelli | Buy | 10,000 | $1.14 |
| Mar 20, 2026 | John A Paganelli | Buy | 10,000 | $1.14 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 89,375 | $1.33 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 191,490 | $1.33 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 3,894 | $1.32 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 102,371 | $1.30 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 192,870 | $1.34 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 89,375 | $1.33 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 191,490 | $1.33 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 3,894 | $1.32 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 102,371 | $1.30 |
| Nov 21, 2025 | Gamma Investments Trust Frost | Buy | 192,870 | $1.34 |
| Nov 21, 2025 | Phillip Md Et Al Frost | Buy | 89,375 | $1.33 |
OPK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $606.88M | $-225.68M | -0.30 | $-178.54M |
| Dec 31, 2024 | $713.14M | $-53.22M | -0.08 | $-183.49M |
| Dec 31, 2023 | $863.50M | $-188.86M | -0.25 | $-28.20M |
| Dec 31, 2022 | $1.00B | $-328.40M | -0.46 | $-95.19M |
| Dec 31, 2021 | $1.77B | $-30.14M | -0.05 | $38.34M |
Latest balance sheet: total assets $1.83B, total liabilities $645.29M, cash $300.76M (as of Jun 30, 2026).
OPK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 27, 2026 | 8-K Item 2.02 (results) | $1.24 |
| Apr 28, 2026 | 8-K Item 2.02 (results) | $1.21 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $1.20 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $1.43 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $1.28 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $1.38 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $1.63 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $1.45 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 6, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on OPK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.